Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
The Developing Nearby Food Development and Its Advantages - 2Scientists dove hundreds of feet into the ocean and found creatures no human has ever seen. Our trash beat us there
- 3The 10 Most Significant Virtual Entertainment Missions
- 4Surging measles cases are 'fire alarm' warning that other diseases could be next
- 5BHP liable for 2015 Brazil mine disaster: UK court
- Israeli forces kill one person in series of attacks on southern Lebanon
- Who was Haytham Ali Tabatabai, Hezbollah's military leader killed by Israel?
- I'm a hypnotherapist who helps day traders who are losing money. Here's why I think hypnosis works.
- Building an Individual Brand: Illustrations from Forces to be reckoned with
- Step by step instructions to Pick an Incineration Urn: Variables to Consider
- 4 Creative Savvy Home Gadgets of 2024: Reforming Home Robotization and Security
- FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
- Vacation destinations in America
- Jesse Jackson hospitalized, under observation for a neurodegenerative condition
